DraftKings (DKNG) stock price targets and analysts’ forecasts by the biggest brokers and major investment banks.
Guggenheim maintains DraftKings DKNG at Buy and lowers the price target from $62 to $61. (4-10-2025)
Needham reiterates DraftKings DKNG at Buy and maintains the price target at $65. (4-7-2025)
Benchmark maintains DraftKings at Buy and raises the price target from $44 to $51. (3-10-2025)
Morgan Stanley maintains DraftKings DKNG at Overweight and raises the price target from $49 to $53. (2-24-2025)
JP Morgan maintains DraftKings DKNG at Overweight and raises the price target from $53 to $61. (2-18-2025)
JMP Securities maintains DraftKings DKNG at Market Outperform and raises the price target from $50 to $60. (2-18-2025)
Wells Fargo maintains DraftKings at Overweight and raises the price target from $53 to $60. (2-18-2025)
Piper Sandler reiterates DraftKings DKNG at Overweight and raises the price target from $48 to $60. (2-18-2025)
Truist Securities maintains DraftKings DKNG at Buy and raises the price target from $50 to $60. (2-18-2025)
Stifel maintains DraftKings DKNG at Buy and raises the price target from $48 to $57. (2-18-2025)
Needham maintains DraftKings at Buy and raises the price target from $60 to $65. (2-18-2025)
Benchmark maintains DraftKings DKNG at Buy and raises the price target from $44 to $51. (2-14-2025)
Canaccord Genuity maintains DraftKings DKNG at Buy and raises the price target from $54 to $60. (2-14-2025)
Needham reiterates DraftKings at Buy and maintains the price target at $60. (2-7-2025)
Susquehanna maintains DraftKings at Positive and lowers the price target from $56 to $54. (1-8-2025)
Benchmark reiterates DraftKings at Buy and maintains the price target at $44. (1-7-2025)
JMP Securities maintains DraftKings DKNG at Market Outperform and lowers the price target from $52 to $50. (1-6-2025)
TD Cowen maintains DraftKings DKNG at Buy and raises the price target from $50 to $55. (11-12-2024)
Macquarie maintains DraftKings DKNG at Outperform and raises the price target from $50 to $51. (11-11-2024)
Barclays maintains DraftKings at Overweight and raises the price target from $45 to $50. (11-11-2024)
JMP Securities maintains DraftKings at Market Outperform and raises the price target from $51 to $52. (11-11-2024)
Needham reiterates DraftKings DKNG at Buy and maintains the price target at $60. (11-8-2024)
Morgan Stanley maintains DraftKings DKNG at Overweight and raises the price target from $47 to $48. (10-22-2024)
Mizuho maintains DKNG at Outperform and raises the price target from $54 to $62. (10-18-2024)
Wells Fargo maintains DKNG at Overweight and raises the price target from $47 to $52. (10-17-2024)
BMO Capital reiterates DraftKings at Outperform and maintains a price target of $48. (10-16-2024)
JMP Securities reiterates DraftKings at Market Outperform and maintains a price target of $51. (10-14-2024)
Benchmark reiterates DraftKings at Buy and maintains a price target of $44. (10-7-2024)
Susquehanna maintains DraftKings DKNG at Positive and raises the price target from $48 to $50. (10-7-2024)
Barclays maintains DraftKings DKNG at Overweight and raises the price target from $43 to $45. (10-4-2024)
JP Morgan maintains DraftKings DKNG at Overweight and raises the price target from $48 to $54. (9-26-2024)
Needham reiterates DraftKings DKNG at Buy and maintains a price target of $60. (9-23-2024)
Needham reiterates DKNG at Buy and maintains a price target of $60. (9-16-2024)
Morgan Stanley reiterates DKNG at Overweight and maintains a price target of $47. (9-11-2024)
Needham reiterates DKNG at Buy and maintains a price target of $60. (9-9-2024)
UBS maintains DraftKings DKNG at Buy and raises the price target from $56 to $58. (9-4-2024)
Susquehanna maintains DKNG at Positive and raises the price target from $47 to $48. (9-4-2024)
Needham reiterates DKNG at Buy and maintains a price target of $60. (9-3-2024)
Benchmark maintains DKNG at Buy and raises the price target from $41 to $44. (8-20-2024)
Truist Securities maintains DKNG at Buy and maintains a price target of $50. (8-14-2024)
Needham reiterates DraftKings at Buy and maintains a price target of $60. (8-14-2024)
Morgan Stanley maintains DraftKings DKNG at Overweight and lowers the price target from $51 to $47. (8-13-2024)
Macquarie maintains DraftKings DKNG at Outperform and lowers the price target from $52 to $50. (8-5-2024)
Oppenheimer maintains DKNG at Outperform and lowers the price target from $58 to $55. (8-5-2024)
Truist Securities maintains DraftKings DKNG at Buy and lowers the price target from $53 to $50. (8-5-2024)
Goldman Sachs maintains DraftKings DKNG at Buy and lowers the price target from $60 to $54. (8-5-2024)
Needham reiterates DraftKings at Buy and maintains the price target at $60. (8-5-2024)
Susquehanna maintains DraftKings DKNG at Positive and lowers the price target from $49 to $47. (8-1-2024)
Needham reiterates DKNG at Buy and maintains a price target of $60. (7-24-2024)
B of A Securities maintains DraftKings DKNG at Buy and lowers the price target from $54 to $50. (7-22-2024)
Macquarie maintains DraftKings DKNG at Outperform and lowers the price target from $54 to $52. (7-18-2024)
Truist Securities maintains DraftKings DKNG at Buy and lowers the price target from $55 to $53. (7-18-2024)
Stifel maintains DraftKings at Buy and maintains a price target of $50. (7-5-2024)
Oppenheimer maintains DraftKings DKNG at Outperform and lowers the price target from $60 to $58. (7-1-2024)
Guggenheim maintains DraftKings DKNG at Buy and lowers the price target from $53 to $52. (6-26-2024)
Wells Fargo maintains DraftKings DKNG at Overweight and lowers the price target from $54 to $53. (6-25-2024)
Needham reiterates DraftKings DKNG at Buy and maintains a price target of $60. (6-12-2024)
Susquehanna maintains DraftKings DKNG at Positive and lowers the price target from $56 to $49. (6-5-2024)
Stifel maintains DraftKings DKNG at Buy and lowers the price target from $51 to $50. (5-29-2024)
Oppenheimer maintains DraftKings DKNG at Outperform and maintains a price target of $60. (5-28-2024)
Needham reiterates DraftKings DKNG at Buy and maintains a price target of $60. (5-28-2024)
UBS maintains DraftKings DKNG at Buy and raises the price target from $56 to $60. (5-6-2024)
Jefferies maintains DraftKings at Buy and raises the price target from $52 to $54. (5-6-2024)
Stifel maintains DraftKings at Buy and raises the price target from $50 to $51. (5-6-2024)
Deutsche Bank maintains DKNG at Hold and raises the price target from $34 to $35. (5-6-2024)
Barclays maintains DKNG at Overweight and raises the price target from $52 to $54. (5-6-2024)
BMO Capital maintains DKNG at Outperform and raises the price target from $51 to $54. (5-6-2024)
BTIG maintains DKNG at Buy and raises the price target from $53 to $55. (5-6-2024)
Needham maintains DKNG at Buy and raises the price target from $58 to $60. (5-6-2024)
Needham reiterates DKNG at Buy and maintains a price target of $58. (5-3-2024)
Susquehanna maintains DKNG at Positive and raises the price target from $54 to $56. (4-29-2024)
Benchmark reiterates DKNG at Buy and maintains a price target of $50. (4-24-2024)
Barclays maintains DKNG at Overweight and raises the price target from $50 to $52. (4-19-2024)
Goldman Sachs initiates coverage on DKNG at Buy and a price target of $60. (4-16-2024)
Morgan Stanley maintains DKNG at Overweight and raises the price target from $49 to $50. (4-9-2024)
JP Morgan maintains DKNG at Overweight and maintains a price target of $55. (3-28-2024)
MoffettNathanson maintains DKNG at Buy and raises the price target from $52 to $55. (3-28-2024)
Needham maintains DKNG at Buy and raises the price target from $54 to $58. (3-27-2024)
Susquehanna maintains DraftKings DKNG at Positive and raises the price target from $51 to $54. (3-26-2024)
Mizuho initiates coverage on DKNG at Buy rating and a price target of $58. (3-26-2024)
Susquehanna maintains DKNG at Positive and raises the price target from $51 to $54. (3-25-2024)
JMP Securities reiterates DKNG at Market Outperform and maintains a price target of $52. (3-25-2024)
UBS maintains DKNG at Buy and raises the price target from $44 to $56. (3-5-2024)
Morgan Stanley maintains DKNG at Overweight and raises the price target from $40 to $49. (2-29-2024)
Needham maintains DKNG at Buy and raises the price target from $50 to $54. (2-20-2024)
Needham reiterates DKNG at Buy and maintains a price target of $50. (2-16-2024)
Exane BNP Paribas downgrades DKNGfrom Neutral to Underperform and a price target of $28. (1-19-2024)
Stifel upgrades DraftKings from Hold to Buy and raises the price target from $40 to $45. (1-19-2024)
BMO Capital initiates coverage on DraftKings DKNG at Outperform rating and a price target of $43. (1-9-2024)
Argus Research maintains DKNG at Buy and raises the price target from $40 to $46. (11-27-2023)
Needham reiterates DraftKings with a Buy and maintains a price target of $50. (11-27-2023)
Guggenheim maintains DraftKings at Buy and raises the price target from $39 to $45. (11-15-2023)
Benchmark maintains DKNG at Buy and raises the price target from $37 to $41. (11-15-2023)
Craig-Hallum maintains DKNG at Buy and raises the price target from $40 to $45. (11-15-2023)
Needham reiterates DKNG at Buy and maintains a price target of $50. (11-13-2023)
Susquehanna maintains DKNG at Positive and raises the price target from $37 to $42. (11-13-2023)
UBS maintains DraftKings at Buy and raises the price target from $39 to $44. (11-7-2023)
Truist Securities maintains DraftKings at Buy and raises the price target from $44 to $45. (11-6-2023)
Needham maintains DraftKings DKNG at Buy and raises the price target from $44 to $50. (11-6-2023)
Guggenheim maintains DKNG at Buy and cuts the price target from $38 to $37. (10-2-2023)
Needham reiterates DraftKings at Buy and maintains a price target of $44. (10-2-2023)
JP Morgan upgrades DraftKings DKNG from Neutral to Overweight and raises the price target from $26 to $37. (9-26-2023)
Needham reiterates DKNG at Buy and maintains a price target of $44. (9-11-2023)
JMP Securities reiterates DKNG at Market Outperform and maintains a price target of $39. (8-18-2023)
Argus Research maintains DKNG at Buy and raises the price target from $30 to $34. (8-10-2023)
JP Morgan upgrades DKNG from Underweight to Neutral and a price target of $26. (8-8-2023)
Truist Securities upgrades DKNG from Hold to Buy and raises the price target from $31 to $44. (8-8-2023)
Craig-Hallum maintains DKNG at Buy and raises the price target from $35 to $40. (8-7-2023)
Deutsche Bank maintains DraftKings DKNG at Hold and raises the price target from $24 to $27. (8-7-2023)
Roth MKM maintains DKNG at Sell and raises the price target from $20 to $23. (8-7-2023)
TD Cowen maintains DKNG at Outperform and raises the price target from $35 to $37. (8-7-2023)
Oppenheimer maintains DKNG at Outperform and raises the price target from $36 to $40. (8-7-2023)
JMP Securities maintains DKNG at Outperform and raises the price target from $33 to $39. (8-7-2023)
Wells Fargo upgrades DKNG from Equal-Weight to Overweight and raises the price target from $28 to $37. (8-7-2023)
Needham maintains DKNG at Buy and raises the price target from $36 to $44. (8-7-2023)
Benchmark maintains DKNG at Buy and raises the price target from $32 to $37. (8-4-2023)
Needham reiterates DKNG at Buy and maintains a price target of $36. (8-4-2023)
Barclays maintains DKNG at Equal-Weight and raises the price target from $24 to $29. (7-21-2023)
Roth MKM maintains DKNG at Sell and raises the price target from $18 to $20. (7-18-2023)
Morgan Stanley reiterates DKNG at Overweight and raises the price target from $31 to $32. (7-14-2023)
JMP Securities maintains DKNG at Outperform and raises the price target from $31 to $33. (7-13-2023)
B of A Securities upgrades DKNG from Neutral to Buy and a price target of $35. (7-12-2023)
Oppenheimer maintains DKNG at Outperform and raises the price target from $30 to $36. (7-7-2023)
Deutsche Bank maintains DKNG at Hold and raises the price target from $22 to $24. (7-6-2023)
Truist Securities reiterates DKNG at Hold and maintains a price target of $26. (6-27-2023)
Wells Fargo maintains DKNG at Equal-Weight and raises the price target from $24 to $28. (6-23-2023)
Morgan Stanley maintains DKNG at Overweight and raises the price target from $25 to $31. (6-5-2023)
BTIG maintains DKNG at Buy and raises the price target from $27 to $31. (6-5-2023)
JMP Securities maintains DraftKings at Market Outperform and raises the price target from $29 to $31. (6-5-2023)
Jefferies maintains DKNG at Buy and raises the price target from $33 to $35. (6-5-2023)
UBS upgrades DKNG from Neutral to Buy and raises the price target from $19 to $30. (5-18-2023)
Needham reiterates DKNG at Buy and maintains a price target of $36. (5-18-2023)
Morgan Stanley maintains DKNG at Overweight and raises the price target from $23 to $25. (5-16-2023)
Benchmark maintains DKNG at Buy and raises the price target from $23 to $26. (5-8-2023)
Truist Securities maintains DKNG at Hold and raises the price target from $23 to $26. (5-8-2023)
Guggenheim maintains DKNG at Buy and raises the price target from $27 to $32. (5-8-2023)
Canaccord Genuity maintains DKNG with a Buy and raises the price target from $30 to $34. (5-8-2023)
TD Cowen maintains DKNG at Outperform and raises the price target from $27 to $30. (5-8-2023)
Barclays maintains DKNG at Equal-Weight and raises the price target from $23 to $24. (5-8-2023)
Deutsche Bank maintains DKNG at Hold and raises the price target from $15 to $22. (5-8-2023)
CFRA downgrades DKNG from Buy to Hold and raises the price target from $25 to $28. (5-5-2023)
Oppenheimer reiterated DKNG at Outperform and raised the price target from $28 to $30. (5-5-2023)
Benchmark maintains DKNG at Buy and raises the price target from $23 to $26. (5-5-2023)
Needham reiterates DKNG at Buy and maintains a price target of $28. (5-5-2023)
BTIG maintains DKNG at Buy and raises the price target from $25 to $27. (5-5-2023)
Morgan Stanley maintains DKNG at Overweight and raises the price target from $22 to $23. (4-18-2023)
Susquehanna maintains DKNG at Positive and raises the price target from $26 to $28. (4-3-2023)
BTIG maintains DKNG at Buy and raises the price target from $24 to $25. (3-13-2023)
Argus Research upgrades DKNG from Hold to Buy and a price target of $22. (3-7-2023)
Craig-Hallum maintains DKNG at Buy and raises the price target from $21 to $27. (2-21-2023)
Canaccord Genuity maintains DKNG at Buy and raises the price target from $28 to $30. (2-21-2023)
Truist Securities maintains DKNG at Hold and raises the price target from $15 to $23. (2-21-2023)
Susquehanna maintains DKNG at Positive and raises the price target from $24 to $26. (2-17-2023)
Needham reiterates DKNG at Buy and a price target of $20. (2-17-2023)
Susquehanna maintains DKNG at Positive and raises the price target from $19 to $24. (2-15-2023)
Stifel maintains DKNG at Hold and raises the price target from $15 to $17. (2-15-2023)
Roth Capital downgrades DKNG from Neutral to Sell and set a price target of $15. (2-9-2023)
Stifel initiates coverage on DKNG at Hold and set a price target of $15. (1-24-2023)
Roth Capital downgrades DKNG from Buy to Neutral and a price target of $15. (12-12-2022)
Morgan Stanley assumes DKNG at Overweight and set a price target of $20. (11-21-2022)
Piper Sandler initiates coverage on DKNG at Overweight and a price target of $21. (11-18-2022)
Stocks, Crypto, Forex and Commodities Breaking News. The latest news and analysis on metals, energy, and agriculture. Live news about gold, silver, copper, platinum, natural gas, crude oil, wheat, soybeans, rice coffee, sugar, cocoa, lumber and cotton.
